My Financial News from Netherlands, Finance

from Bing and Google News
Netherlands , Thursday 16 April 2026

Lava Therapeutics B.V. (NASDAQ:LVTX) Cut to Hold at Zacks Investment Research

Published on: Monday 28 March 2022

Lava Therapeutics B.V. (NASDAQ:LVTX) Cut to Hold at Zacks Investment Research Zacks Investment Research cut shares of Lava Therapeutics B.V. (NASDAQ:LVTX – Get Rating) from a buy rating to a hold rating in a report published on Saturday, Zacks.com reports. According to Zacks, “LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy. […]


News source: https://www.etfdailynews.com/2022/03/29/lava-therapeutics-b-v-nasdaqlvtx-cut-to-hold-at-zacks-investment-research/

Share this news on:  

RELATED NEWS

» MYT Netherlands Parent B.V. (NYSE:MYTE) Stock Rating Upgraded by UBS Group
» Lava Therapeutics B.V. (NASDAQ:LVTX) Cut to Hold at Zacks Investment Research
» Locus Robotics Chosen by GXO to Support Its Logistics Solution for Customer Warehouses in the U.K. and Netherlands
» Dutch government is failing to investigate Russian property ownership: NOS
» Dutch cabinet wants to triple flight tax: adding €24 to ticket prices

HEADLINE NEWS